相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity
Manali S. Phadke et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance
Inna Smalley et al.
CLINICAL CANCER RESEARCH (2020)
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease
David Gate et al.
NATURE (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma
Benjamin P. Fairfax et al.
NATURE MEDICINE (2020)
Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions
Isabella C. Glitza et al.
PIGMENT CELL & MELANOMA RESEARCH (2020)
Targeted deletion of PD-1 in myeloid cells induces antitumor immunity
Laura Strauss et al.
SCIENCE IMMUNOLOGY (2020)
SingleCellSignalR: inference of intercellular networks from single-cell transcriptomics
Simon Cabello-Aguilar et al.
NUCLEIC ACIDS RESEARCH (2020)
The Association of MUC16 Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous Melanoma
Xuefeng Wang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
O. Hamid et al.
ANNALS OF ONCOLOGY (2019)
Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD)
Sherise D. Ferguson et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases
Grant M. Fischer et al.
CANCER DISCOVERY (2019)
Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species
Rapolas Zilionis et al.
IMMUNITY (2019)
Estimation of immune cell content in tumor using single-cell RNA-seq reference data
Xiaoqing Yu et al.
BMC CANCER (2019)
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
C. Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Single-Cell Signature Explorer for comprehensive visualization of single cell signatures across scRNA-seq datasets
Frederic Pont et al.
NUCLEIC ACIDS RESEARCH (2019)
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
Dvir Aran et al.
NATURE IMMUNOLOGY (2019)
Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies
Elham Vosoughi et al.
BMC CANCER (2018)
Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
Georgina Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Andrew Butler et al.
NATURE BIOTECHNOLOGY (2018)
Myeloid-derived suppressor cells coming of age
Filippo Veglia et al.
NATURE IMMUNOLOGY (2018)
Tissue-Specific Immunoregulation: A Call for Better Understanding of the Immunostat in the Context of Cancer
William Pao et al.
CANCER DISCOVERY (2018)
The proportion of circulating CD45RO+CD8+ memory T cells is correlated with clinical response in melanoma patients treated with ipilimumab
Julia K. Tietze et al.
EUROPEAN JOURNAL OF CANCER (2017)
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
Michael A. Davies et al.
LANCET ONCOLOGY (2017)
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
Alexandra-Chloe Villani et al.
SCIENCE (2017)
Massively parallel digital transcriptional profiling of single cells
Grace X. Y. Zheng et al.
NATURE COMMUNICATIONS (2017)
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma
Alexandre Reuben et al.
NPJ GENOMIC MEDICINE (2017)
SinCHet: a MATLAB toolbox for single cell heterogeneity analysis in cancer
Jiannong Li et al.
BIOINFORMATICS (2017)
Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204.
Hussein Abdul-Hassan Tawbi et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases
Heike Seifert et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
A High-Dimensional Atlas of Human T Cell Diversity Reveals Tissue-Specific Trafficking and Cytokine Signatures
Michael Thomas Wong et al.
IMMUNITY (2016)
Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy
Keiran S. M. Smalley et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Management of Brain Metastases in ALK-Positive Non-Small-Cell Lung Cancer
Chad G. Rusthoven et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future
Claudia Proto et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination
J. Zachary Sanborn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Priscilla K. Brastianos et al.
CANCER DISCOVERY (2015)
Melanoma metastasis: new concepts and evolving paradigms
W. E. Damsky et al.
ONCOGENE (2014)
Inter- and Intra-Patient Heterogeneity of Response and Progression to Targeted Therapy in Metastatic Melanoma
Alexander M. Menzies et al.
PLOS ONE (2014)
Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab
Saskia J. A. M. Santegoetst et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Novel Treatments for Melanoma Brain Metastases
Rajappa S. Kenchappa et al.
CANCER CONTROL (2013)
CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation
Ivan Zanoni et al.
NATURE (2009)
Brain and leptomeningeal metastases from cutaneous melanoma: Survival outcomes based on clinical features
Jeffrey J. Raizer et al.
NEURO-ONCOLOGY (2008)
Prognostic factors and outcomes in patients with leptomeningeal melanomatosis
Laura Harstad et al.
NEURO-ONCOLOGY (2008)
Diversity of regulatory CD4+ T cells controlling distinct organ-specific autoimmune diseases
MA Alyanakian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
